Literature DB >> 21177257

Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases.

Yong Ren1, Houbo Jiang, Dingyuan Ma, Kazuhiro Nakaso, Jian Feng.   

Abstract

Parkin, whose mutations cause Parkinson disease (PD), controls oxidative stress by limiting the expression of monoamine oxidases (MAO)--mitochondrial enzymes responsible for the oxidative de-amination of dopamine. Here, we show that parkin performed this function by increasing the ubiquitination and degradation of estrogen-related receptors (ERR), orphan nuclear receptors that play critical roles in the transcription regulation of many nuclear-encoded mitochondrial proteins. All three ERRs (α, β and γ) increased the transcription of MAOs A and B; the effects were abolished by parkin, but not by its PD-linked mutants. Parkin bound to ERRs and increased their ubiquitination and degradation. In fibroblasts from PD patients with parkin mutations or brain slices from parkin knockout mice, degradation of ERRs was significantly attenuated. The results reveal the molecular mechanism by which parkin suppresses the transcription of MAOs to control oxidative stress induced by dopamine oxidation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177257      PMCID: PMC3043659          DOI: 10.1093/hmg/ddq550

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

1.  Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.

Authors:  Yong Ren; Jinghui Zhao; Jian Feng
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Identification of a new class of steroid hormone receptors.

Authors:  V Giguère; N Yang; P Segui; R M Evans
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.

Authors:  Sylvia N Schreiber; Roger Emter; M Benjamin Hock; Darko Knutti; Jessica Cardenas; Michael Podvinec; Edward J Oakeley; Anastasia Kralli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

4.  Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.

Authors:  Yakov Pesah; Tuan Pham; Heather Burgess; Brooke Middlebrooks; Patrik Verstreken; Yi Zhou; Mark Harding; Hugo Bellen; Graeme Mardon
Journal:  Development       Date:  2004-04-08       Impact factor: 6.868

5.  Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.

Authors:  Houbo Jiang; Yong Ren; Jinghui Zhao; Jian Feng
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

6.  Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline).

Authors:  P Riederer; K Jellinger
Journal:  Acta Neurol Scand Suppl       Date:  1983

7.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Authors:  J A Javitch; R J D'Amato; S M Strittmatter; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 8.  3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.

Authors:  W J Burke
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2003-04

9.  Pargyline prevents MPTP-induced parkinsonism in primates.

Authors:  J W Langston; I Irwin; E B Langston; L S Forno
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

10.  Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.

Authors:  James J Palacino; Dijana Sagi; Matthew S Goldberg; Stefan Krauss; Claudia Motz; Maik Wacker; Joachim Klose; Jie Shen
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

View more
  33 in total

Review 1.  Redefining Parkinson's disease research using induced pluripotent stem cells.

Authors:  Jiali Pu; Houbo Jiang; Baorong Zhang; Jian Feng
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.

Authors:  Mary M Heckler; Hemang Thakor; Cara C Schafer; Rebecca B Riggins
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

3.  Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.

Authors:  Houbo Jiang; Yong Ren; Eunice Y Yuen; Ping Zhong; Mahboobe Ghaedi; Zhixing Hu; Gissou Azabdaftari; Kazuhiro Nakaso; Zhen Yan; Jian Feng
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

Review 4.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

5.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

6.  Insights into the activation mechanism of human estrogen-related receptor γ by environmental endocrine disruptors.

Authors:  Erwan Thouennon; Vanessa Delfosse; Rémy Bailly; Pauline Blanc; Abdelhay Boulahtouf; Marina Grimaldi; Alessandro Barducci; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2019-05-24       Impact factor: 9.261

7.  Eating disorder predisposition is associated with ESRRA and HDAC4 mutations.

Authors:  Huxing Cui; Jarrette Moore; Sunbola S Ashimi; Brittany L Mason; Jordan N Drawbridge; Shizhong Han; Benjamin Hing; Abigail Matthews; Carrie J McAdams; Benjamin W Darbro; Andrew A Pieper; David A Waller; Chao Xing; Michael Lutter
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα.

Authors:  Susan M Krzysik-Walker; Isabel González-Mariscal; Morten Scheibye-Knudsen; Fred E Indig; Michel Bernier
Journal:  Mol Pharmacol       Date:  2012-10-12       Impact factor: 4.436

Review 9.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

10.  The Role of Parkin in Parkinson's Disease: a stem cell perspective.

Authors: 
Journal:  Neurodegener Dis Manag       Date:  2012-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.